Which Is the Mitral Prosthesis of Choice in Dialysis Patients? The Debate Continues
This single-center, retrospective American study evaluates outcomes of prosthesis choice in patients with advanced renal disease on dialysis.
This single-center, retrospective American study evaluates outcomes of prosthesis choice in patients with advanced renal disease on dialysis.
Definition of Framework Criteria of the Valve Academic Research Consortium for Characterizing Tricuspid Regurgitation and Setting Outcomes in Subsequent Studies on Its Invasive Treatment
A retrospective study from two European centers with extensive experience using Edwards Intuity® bioprostheses comparing their perioperative and five-year outcomes with the Carpentier Edwards Magna Ease® bioprosthesis in combined aortic valve replacement and coronary artery bypass grafting (CABG).
An update on outcomes and impressions from the recent TCT Congress in San Francisco on studies examining TAVI vs. surgical aortic valve replacement in low-risk patients: PARTNER 3, Evolut-Low Risk, and NOTION.
A multicenter study based on NEOPRO and NEOPRO-2 registries analyzes the prognostic impact and predictors of pacemaker implantation following Medtronic Evolut® and Acurate NEO® self-expanding TAVI.
A retrospective study of a national database in Taiwan that examines durability outcomes for all bioprosthetic valves implanted in the aortic and/or mitral position from 2001 to 2017.
This blog article summarizes and presents the main updates to the 2023 clinical guidelines on infective endocarditis (IE) by the European Society of Cardiology (ESC).
This editorial article thoroughly details the perioperative guidelines and surgical technique for aortic valve replacement with a Perceval sutureless prosthesis in patients undergoing concomitant mitral surgery.
An analysis by the Cleveland Clinic of isolated tricuspid valve surgery outcomes, focusing on etiology and associated clinical and analytical parameters.
Analysis of the foundational work of the TRI-SCORE scoring system, designed to assess the risk-benefit balance of invasive treatment options versus conservative management in patients with significant isolated tricuspid regurgitation (TR).